MedPath

Alliance for Clinical Trials in Oncology

Alliance for Clinical Trials in Oncology logo
🇺🇸United States
Ownership
Private
Established
2011-01-01
Employees
251
Market Cap
-
Website
https://www.allianceforclinicaltrialsinoncology.org

Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

First Posted Date
2004-05-25
Last Posted Date
2016-07-20
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
80
Registration Number
NCT00004139
Locations
🇺🇸

CCOP - Greenville, Greenville, South Carolina, United States

🇺🇸

Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington, District of Columbia, United States

🇺🇸

Walter Reed Army Medical Center, Washington, District of Columbia, United States

and more 5 locations

Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer

Phase 2
Completed
Conditions
Pancreatic Cancer
Interventions
First Posted Date
2004-05-25
Last Posted Date
2016-07-14
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
59
Registration Number
NCT00004190
Locations
🇺🇸

CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States

🇺🇸

CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States

🇺🇸

CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota, United States

and more 16 locations

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

Completed
Conditions
Prostate Cancer
Interventions
Other: mutation analysis
First Posted Date
2004-05-24
Last Posted Date
2016-07-14
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
184
Registration Number
NCT00002924
Locations
🇺🇸

University of California San Diego Cancer Center, La Jolla, California, United States

🇺🇸

Walter Reed Army Medical Center, Washington, District of Columbia, United States

🇺🇸

CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States

and more 46 locations

Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Phase 2
Completed
Conditions
Lymphoma
Interventions
First Posted Date
2004-05-21
Last Posted Date
2016-06-28
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
53
Registration Number
NCT00002880
Locations
🇺🇸

Washington University Barnard Cancer Center, Saint Louis, Missouri, United States

🇺🇸

St. Joseph's Hospital and Medical Center, Paterson, New Jersey, United States

🇺🇸

Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States

and more 1 locations

Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases

Phase 3
Completed
Conditions
Metastatic Cancer
Interventions
Procedure: surgical procedure
First Posted Date
2004-05-21
Last Posted Date
2016-07-12
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
530
Registration Number
NCT00003724
Locations
🇺🇸

University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States

🇺🇸

Veterans Affairs Medical Center - Columbia (Truman Memorial), Columbia, Missouri, United States

🇺🇸

Veterans Affairs Medical Center - Togus, Togus, Maine, United States

and more 42 locations

Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia

Phase 2
Completed
Conditions
Leukemia
Interventions
First Posted Date
2004-05-20
Last Posted Date
2016-07-12
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
38
Registration Number
NCT00003255

Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

First Posted Date
2004-05-20
Last Posted Date
2016-07-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
163
Registration Number
NCT00003700
Locations
🇺🇸

University of Illinois at Chicago Health Sciences Center, Chicago, Illinois, United States

🇺🇸

University of Chicago Cancer Research Center, Chicago, Illinois, United States

🇺🇸

Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States

and more 47 locations

Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

Phase 3
Completed
Conditions
Esophageal Cancer
Interventions
Drug: cisplatin
Drug: fluorouracil
Procedure: surgical procedure
Radiation: radiation therapy
First Posted Date
2004-05-19
Last Posted Date
2016-07-04
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
56
Registration Number
NCT00003118
Locations
🇺🇸

University of Illinois at Chicago Health Sciences Center, Chicago, Illinois, United States

🇺🇸

University of Chicago Cancer Research Center, Chicago, Illinois, United States

🇺🇸

Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States

and more 35 locations

Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer

Phase 3
Completed
Conditions
Lung Cancer
Interventions
First Posted Date
2004-05-19
Last Posted Date
2016-06-30
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
584
Registration Number
NCT00003117
Locations
🇺🇸

Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

🇺🇸

CCOP - Christiana Care Health Services, Wilmington, Delaware, United States

🇺🇸

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

and more 32 locations

Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Interventions
First Posted Date
2004-05-03
Last Posted Date
2016-07-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
48
Registration Number
NCT00003900
Locations
🇺🇸

Siouxland Hematology-Oncology, Sioux City, Iowa, United States

🇺🇸

CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States

🇨🇦

Saskatchewan Cancer Agency, Regina, Saskatchewan, Canada

and more 16 locations
© Copyright 2025. All Rights Reserved by MedPath